Stage (next event)
Phase 2b On hold
Catalyst Info & Data Links
TITLE: Etokimab (ANB020): Anti-IL-33 for Eosinophilic Asthma Phase 2b on hold
Clinical Trial (NCT03469934) Proof of Concept Study to Investigate ANB020 Activity in Adult Patients With Severe Eosinophilic Asthma
WHAT IS THE NEXT CATALYST EVENT?
Phase 2b on-hold
WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?
Mechanism of Action
Updated by MV
Prior Data (click to view full image)
Trial Design / Revenue (click to view full image)
See what the community is saying - click to see full post